Bourke, Caitlin
Takashima, Eizo
Chan, Li-Jin
Dietrich, Melanie H.
Mazhari, Ramin
White, Michael
Sattabongkot, Jetsumon
Tham, Wai-Hong
Tsuboi, Takafumi
Mueller, Ivo
Longley, Rhea https://orcid.org/0000-0002-4510-5602
Funding for this research was provided by:
National Health and Medical Research Council (1092789)
National Health and Medical Research Council (1134989)
National Health and Medical Research Council (1043345)
National Health and Medical Research Council (1143187)
National Health and Medical Research Council (1173210)
National Institute of Allergy and Infectious Diseases (5R01 AI 104822)
Global Health Innovative Technology Fund (T2015-142)
Howard Hughes Medical Institute-Wellcome International Research Scholar (208693/Z/17/Z)
Article History
Received: 16 November 2021
Accepted: 13 February 2022
First Online: 4 March 2022
Declarations
:
: The Ethics Committee of Faculty of Tropical Medicine, Mahidol University, Thailand approved the twelve-month observational cohort (MUTM 2013-027-01) and nine-month clinical cohort (MUTM 2014-025-01 and 02). The Human Research Ethics Committee, Walter and Eliza Hall Institute of Medical Research, Australia approved the use of collected samples in Melbourne (14/02), and approved collection and/or use of the negative control samples (14/02).
: Not applicable.
: RJL, MW, TT and IM are inventors on patent PCT/US17/67926 on a system, method, apparatus and diagnostic test for <i>Plasmodium vivax.</i>